Atlas Trials

Diffuse Large-cell B-cell Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Diffuse Large-cell B-cell Lymphoma

RecordFirmDate
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) (NCT05328102)Xencor, Inc.2022-04-15

Track Diffuse Large-cell B-cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.